Recently there is a lot of advancement in the understanding of gut microbiome in health and disease. Initial studies of selected probiotic species (given alone or in combination) have suggested potential efficacy in several gastrointestinal illnesses, the best studied of which are the inflammatory bowel diseases (particularly pouchitis). Therapeutic benefit has also been suggested in several other disorders, including antibiotic-related diarrhoea, Clostridium difficile toxin-induced colitis, infectious diarrhoea, hepatic encephalopathy, irritable bowel syndrome, and allergy. Some of the more commonly available probiotics include: ( Bifidobacterium breve, B. longum, B. infantis, Lactobacillus acidophilus, L. plantarum, L.
paracasei, L. bulgaricus, Streptococcus thermophilus ) Align ( B. infantis ) Culturelle ( L. rhamnosus GG) DanActive ( L. casei ) Mutaflor ( E. coli Nissle) Florastor (…
